Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: A preliminary study

Kenji Hashimoto, Tamaki Ishima, Yasunori Sato, Davide Bruno, Jay Nierenberg, Charles R. Marmar, Henrik Zetterberg, Kaj Blennow, Nunzio Pomara

研究成果: Article

3 引用 (Scopus)

抄録

Major depressive disorder (MDD) in the elderly is a risk factor for dementia, but the precise biological basis remains unknown, hampering the search for novel biomarkers and treatments. In this study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderly patients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18). The CSF levels of 177 substances were measured, while 288 substances were below the detection limit. Only ascorbic acid was significantly different, with higher levels in the MDD group at baseline. There were no correlations between CSF ascorbic acid levels and clinical variables in MDD patients at baseline. At the 3-year follow-up, there was no difference of CSF ascorbic acid levels between the two groups. There was a negative correlation between CSF ascorbic acid and CSF amyloid-β42 levels in all subjects. However, there were no correlations between ascorbic acid and other biomarkers (e.g., amyloid-β40, total and phosphorylated tau protein). This preliminary study suggests that abnormalities in the transport and/or release of ascorbic acid might play a role in the pathogenesis of late-life depression.

元の言語English
記事番号3485
ジャーナルScientific reports
7
発行部数1
DOI
出版物ステータスPublished - 2017 12 1
外部発表Yes

Fingerprint

Ascorbic Acid
Cerebrospinal Fluid
Major Depressive Disorder
Depression
Amyloid
Biomarkers
tau Proteins
Metabolomics
Dementia
Limit of Detection

ASJC Scopus subject areas

  • General

これを引用

Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression : A preliminary study. / Hashimoto, Kenji; Ishima, Tamaki; Sato, Yasunori; Bruno, Davide; Nierenberg, Jay; Marmar, Charles R.; Zetterberg, Henrik; Blennow, Kaj; Pomara, Nunzio.

:: Scientific reports, 巻 7, 番号 1, 3485, 01.12.2017.

研究成果: Article

Hashimoto, K, Ishima, T, Sato, Y, Bruno, D, Nierenberg, J, Marmar, CR, Zetterberg, H, Blennow, K & Pomara, N 2017, 'Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: A preliminary study', Scientific reports, 巻. 7, 番号 1, 3485. https://doi.org/10.1038/s41598-017-03836-0
Hashimoto, Kenji ; Ishima, Tamaki ; Sato, Yasunori ; Bruno, Davide ; Nierenberg, Jay ; Marmar, Charles R. ; Zetterberg, Henrik ; Blennow, Kaj ; Pomara, Nunzio. / Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression : A preliminary study. :: Scientific reports. 2017 ; 巻 7, 番号 1.
@article{f1f52404994b404cbf35fa1c172ab450,
title = "Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: A preliminary study",
abstract = "Major depressive disorder (MDD) in the elderly is a risk factor for dementia, but the precise biological basis remains unknown, hampering the search for novel biomarkers and treatments. In this study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderly patients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18). The CSF levels of 177 substances were measured, while 288 substances were below the detection limit. Only ascorbic acid was significantly different, with higher levels in the MDD group at baseline. There were no correlations between CSF ascorbic acid levels and clinical variables in MDD patients at baseline. At the 3-year follow-up, there was no difference of CSF ascorbic acid levels between the two groups. There was a negative correlation between CSF ascorbic acid and CSF amyloid-β42 levels in all subjects. However, there were no correlations between ascorbic acid and other biomarkers (e.g., amyloid-β40, total and phosphorylated tau protein). This preliminary study suggests that abnormalities in the transport and/or release of ascorbic acid might play a role in the pathogenesis of late-life depression.",
author = "Kenji Hashimoto and Tamaki Ishima and Yasunori Sato and Davide Bruno and Jay Nierenberg and Marmar, {Charles R.} and Henrik Zetterberg and Kaj Blennow and Nunzio Pomara",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-03836-0",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression

T2 - A preliminary study

AU - Hashimoto, Kenji

AU - Ishima, Tamaki

AU - Sato, Yasunori

AU - Bruno, Davide

AU - Nierenberg, Jay

AU - Marmar, Charles R.

AU - Zetterberg, Henrik

AU - Blennow, Kaj

AU - Pomara, Nunzio

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Major depressive disorder (MDD) in the elderly is a risk factor for dementia, but the precise biological basis remains unknown, hampering the search for novel biomarkers and treatments. In this study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderly patients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18). The CSF levels of 177 substances were measured, while 288 substances were below the detection limit. Only ascorbic acid was significantly different, with higher levels in the MDD group at baseline. There were no correlations between CSF ascorbic acid levels and clinical variables in MDD patients at baseline. At the 3-year follow-up, there was no difference of CSF ascorbic acid levels between the two groups. There was a negative correlation between CSF ascorbic acid and CSF amyloid-β42 levels in all subjects. However, there were no correlations between ascorbic acid and other biomarkers (e.g., amyloid-β40, total and phosphorylated tau protein). This preliminary study suggests that abnormalities in the transport and/or release of ascorbic acid might play a role in the pathogenesis of late-life depression.

AB - Major depressive disorder (MDD) in the elderly is a risk factor for dementia, but the precise biological basis remains unknown, hampering the search for novel biomarkers and treatments. In this study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderly patients (N = 28) with MDD and age- and gender-matched healthy controls (N = 18). The CSF levels of 177 substances were measured, while 288 substances were below the detection limit. Only ascorbic acid was significantly different, with higher levels in the MDD group at baseline. There were no correlations between CSF ascorbic acid levels and clinical variables in MDD patients at baseline. At the 3-year follow-up, there was no difference of CSF ascorbic acid levels between the two groups. There was a negative correlation between CSF ascorbic acid and CSF amyloid-β42 levels in all subjects. However, there were no correlations between ascorbic acid and other biomarkers (e.g., amyloid-β40, total and phosphorylated tau protein). This preliminary study suggests that abnormalities in the transport and/or release of ascorbic acid might play a role in the pathogenesis of late-life depression.

UR - http://www.scopus.com/inward/record.url?scp=85020510224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020510224&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-03836-0

DO - 10.1038/s41598-017-03836-0

M3 - Article

C2 - 28615661

AN - SCOPUS:85020510224

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3485

ER -